Study Summary
This trial will measure how exercise affects cancer survivors' chemotherapy treatment and its effectiveness.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 12- or 24-weeks
Trial Safety
Phase-Based Safety
Trial Design
5 Treatment Groups
75 min/wk aerobic exercise
1 of 5
150 min/wk aerobic exercise
1 of 5
300 min/wk aerobic exercise
1 of 5
225 min/wk aerobic exercise
1 of 5
Attention control
1 of 5
Experimental Treatment
Non-Treatment Group
219 Total Participants · 5 Treatment Groups
Primary Treatment: 75 min/wk aerobic exercise · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any openings for enrolment in this clinical investigation?
"Affirmative. Clinical trials.gov lists this clinical trial as being open for recruitment, having been first posted on May 1st 2023 and last updated on May 5th of the same year. A total of 219 patients are sought from 3 distinct sites." - Anonymous Online Contributor
How many participants have been recruited for this clinical investigation?
"Affirmative. According to the clinicaltrials.gov listing, this study is open for enrollment and has been since May 1st 2023 with its last update on May 5th 2023. 219 participants are needed between 3 different healthcare facilities." - Anonymous Online Contributor